Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIK1 | P39086 | 2/20 | 0.53 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.53 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.50 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.50 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.49 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.49 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.47 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.46 |
| ▸ | PPARG | P37231 | 6/20 | 0.46 |
| ▸ | PPARD | Q03181 | 6/20 | 0.46 |
| ▸ | PPARA | Q07869 | 6/20 | 0.46 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.46 |
| ▸ | TSHR | P16473 | 4/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | TLR2 | O60603 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | FABP4 | P15090 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8379986 | 1.00 | GRIK1 (0.53) | GRIK1GRIK2SLC1A2SLC1A1FFAR4 | |
| SCHEMBL2479660 | 1.00 | GRIK1 (0.53) | GRIK1GRIK2SLC1A2SLC1A1FFAR4 | |
| SCHEMBL2480793 | 1.00 | GRIK1 (0.53) | GRIK1GRIK2SLC1A2SLC1A1FFAR4 | |
| SCHEMBL8469261 | 1.00 | GRIK1 (0.53) | GRIK1GRIK2SLC1A2SLC1A1FFAR4 | |
| SCHEMBL2449743 | 1.00 | GRIK1 (0.53) | GRIK1GRIK2SLC1A2SLC1A1FFAR4 | |
| E388 SCHEMBL31317498 | 0.98 | GRIK1 (0.51) | GRIK1GRIK2SLC1A2SLC1A1FFAR4 | |
| SCHEMBL4539291 | 0.98 | GRIK1 (0.51) | GRIK1GRIK2SLC1A2SLC1A1FFAR4 | |
| SCHEMBL9069126 | 0.94 | FOLH1 (0.51) | GRIK1GRIK2SLC1A2SLC1A1FFAR4 | |
| SCHEMBL9008368 | 0.92 | PPARG (0.54) | FFAR4FFAR1PPARGPPARDPPARA | |
| SCHEMBL9108768 | 0.88 | GRIK1 (0.53) | GRIK1GRIK2SLC1A2SLC1A1FFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1326915-B1 | POLYOLEFIN ARTICLES WITH LONG-TERM ELEVATED TEMPERATURE STABILITY | CLARIANT FINANCE BVI LTD (VG) | 2005-11-09 | — | — | EP | claimed |
| EP-3553146-B1 | ADHESIVE COMPOSITION AND USE OF SAME | TOAGOSEI CO LTD (JP) | 2024-11-27 | — | — | EP | disclosed |
| US-20240151879-A1 | OPTICAL FILM, DISPLAY DEVICE, AND COMPOSITION FOR FORMING COLORED LAYER | TOPPAN INC. (JP) | 2024-05-09 | — | — | US | disclosed |
| US-20240004113-A1 | ADHESIVE SHEET, OPTICAL SHEET, DISPLAY DEVICE, AND ADHESIVE LAYER-FORMING COMPOSITION | TOPPAN INC. (JP) | 2024-01-04 | — | — | US | disclosed |
| US-20230092624-A1 | FLAME RETARDANT COMPOSITION, FLAME-RESISTANT SYNTHETIC RESIN COMPOSITION, AND MOLDED BODY | ADEKA CORPORATION (JP) | 2023-03-23 | — | — | US | disclosed |
| US-11421134-B2 | Pressure-sensitive adhesive composition and use therefor | TOAGOSEI CO., LTD. (JP) | 2022-08-23 | — | — | US | disclosed |
| US-20220049092-A1 | POLYCARBONATE RESIN COMPOSITION | TEIJIN LIMITED (JP) | 2022-02-17 | — | — | US | disclosed |
| US-20220000906-A1 | CROSSLINKED CATION EXCHANGE POLYMERS, COMPOSITIONS AND USE IN TREATING HYPERKALEMIA | VIFOR (INTERNATIONAL) LTD. (CH) | 2022-01-06 | — | — | US | disclosed |
| US-20210038636-A1 | POTASSIUM BINDING POLYMERS FOR TREATING HYPERTENSION AND HYPERKALEMIA | VIFOR (INTERNATIONAL) LTD. (CH) | 2021-02-11 | — | — | US | disclosed |
| US-20190322911-A1 | PRESSURE-SENSITIVE ADHESIVE COMPOSITION AND USE THEREFOR | TOAGOSEI CO. LTD. (JP) | 2019-10-24 | — | — | US | disclosed |
| EP-3553146-A1 | ADHESIVE COMPOSITION AND USE OF SAME | Toagosei Co., Ltd. (JP) | 2019-10-16 | — | — | EP | disclosed |
| EP-1947725-B1 | Polymer electrolyte composition and fuel cell | SUMITOMO CHEMICAL CO (JP) | 2011-10-19 | — | — | EP | disclosed |
| EP-1947725-A2 | Polymer electrolyte composition and fuel cell | Sumitomo Chemical Company, Limited (JP) | 2008-07-23 | — | — | EP | disclosed |
| EP-1289041-B1 | Polymer electrolyte composition and fuel cell | SUMITOMO CHEMICAL CO (JP) | 2008-03-12 | — | — | EP | disclosed |
| US-20060257706-A1 | POLYMER ELECTROLYTE COMPOSITION AND FUEL CELL | HIDAKA YASUAKI | 2006-11-16 | — | — | US | disclosed |
| US-20030113605-A1 | Polymer electrolyte composition and fuel cell | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2003-06-19 | — | — | US | disclosed |
| EP-1289041-A2 | Polymer electrolyte composition and fuel cell | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2003-03-05 | — | — | EP | disclosed |
| WO-2002074873-A1 | UV RESISTANT HOT MELT PRESSURE SENSITIVE ADHESIVES | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2002-09-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210038636-A1 | POTASSIUM BINDING POLYMERS FOR TREATING HYPERTENSION AND HYPERKALEMIA | REN, AGTR2, KLK2 | GRIK1 957/4885GRIK2 566/4885SLC1A2 1362/4885 |
| US-20220000906-A1 | CROSSLINKED CATION EXCHANGE POLYMERS, COMPOSITIONS AND USE IN TREATING HYPERKALEMIA | ABCB11, SLC26A3, KCNN3 | GRIK1 259/4885GRIK2 284/4885SLC1A2 304/4885 |
| US-20220049092-A1 | POLYCARBONATE RESIN COMPOSITION | SULT1A1, RRS1, RPS24 | GRIK1 1237/4885GRIK2 1807/4885SLC1A2 3393/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.